Ornithine transcarbamylase (OTC) deficiency is an X-linked disorder that causes recurrent and life-threatening episodes of hyperammonemia. The clinical picture in heterozygous females is highly diverse and derives from the genotype and the degree of inactivation of the mutated X chromosome in hepatocytes. Here, we describe molecular genetic, biochemical, and histopathological findings in the livers explanted from two female patients with late-onset OTC deficiency. Analysis of X-inactivation ratios by DNA methylation-based assays showed remarkable intra-organ variation ranging from 46:54 to 82:18 (average 70:30, n = 37), in favor of the active X chromosome carrying the mutation c.583G>C (p.G195R), in the first patient and from 75:25 to 90:10 (average 82:18, n = 20) in favor of the active X chromosome carrying the splicing mutation c.663+1G>A in the second patient. The X-inactivation ratios in liver samples correlated highly with the proportions of OTC-positive hepatocytes calculated from high-resolution image analyses of the immunohistochemically detected OTC in frozen sections that was performed on total area > 5 cm2. X-inactivation ratios in blood in both female patients corresponded to the lower limit of the liver values. Our data indicate that the proportion of about 20-30% of hepatocytes expressing the functional OTC protein is not sufficient to maintain metabolic stability. X-inactivation ratios assessed in liver biopsies taken from heterozygous females with X-linked disorders should not be considered representative of the whole liver.

Department of Clinical and Transplant Pathology Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Pediatrics and Adolescent Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Institute of Histology and Embryology 1st Faculty of Medicine Charles University Prague Czech Republic

Laboratory of Experimental Hepatology Institute for Clinical and Experimental Medicine Prague Czech Republic

Research Unit for Rare Diseases Department of Pediatrics and Adolescent Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Ke Karlovu 2 128 08 Prague 2 Czech Republic

See more in PubMed

World J Gastroenterol. 2014 Jul 14;20(26):8491-504 PubMed

J Hum Genet. 1998;43(1):54-8 PubMed

Mol Genet Metab Rep. 2015 Jan 10;2:47-50 PubMed

Bioinformatics. 2011 Nov 1;27(21):2987-93 PubMed

Genome Biol. 2013 Apr 25;14(4):R36 PubMed

J Biol Chem. 2009 May 15;284(20):13669-75 PubMed

Nature. 2017 Feb 16;542(7641):352-356 PubMed

J Pediatr Gastroenterol Nutr. 2005 Apr;40(4):471-6 PubMed

Hum Mutat. 2006 Nov;27(11):1159 PubMed

Mol Cell. 2011 Jan 21;41(2):139-49 PubMed

Pediatr Res. 1989 Jul;26(1):77-82 PubMed

Cell. 2009 May 1;137(3):560-70 PubMed

Hum Mutat. 1994;4(1):57-60 PubMed

Mol Genet Metab. 2012 Mar;105(3):404-7 PubMed

Prog Mol Biol Transl Sci. 2010;97:127-50 PubMed

Clin Genet. 2013 Dec;84(6):552-9 PubMed

Mol Genet Metab. 2013 Mar;108(3):161-5 PubMed

Hepatology. 1997 Aug;26(2):365-73 PubMed

Pediatr Transplant. 2017 Feb;21(1): PubMed

Am J Pathol. 1997 Aug;151(2):413-21 PubMed

Pediatr Transplant. 2012 Sep;16(6):E196-200 PubMed

J Hum Genet. 2015 Sep;60(9):501-7 PubMed

J Med Genet. 2015 Nov;52(11):784-90 PubMed

Blood Cells Mol Dis. 2015 Feb;54(2):210-6 PubMed

Clin Genet. 1998 Oct;54(4):349-53 PubMed

Orphanet J Rare Dis. 2014 Jul 16;9:105 PubMed

Am J Hum Genet. 1992 Dec;51(6):1229-39 PubMed

Am J Med Genet. 1997 Sep 5;71(4):378-83 PubMed

Adv Metab Disord. 1964;13:1-44 PubMed

Neuron. 2014 Jan 8;81(1):103-19 PubMed

Neuromuscul Disord. 2015 Jun;25(6):493-501 PubMed